93 related articles for article (PubMed ID: 31588922)
1. Comparison of a retroviral protease in monomeric and dimeric states.
Wosicki S; Gilski M; Zabranska H; Pichova I; Jaskolski M
Acta Crystallogr D Struct Biol; 2019 Oct; 75(Pt 10):904-917. PubMed ID: 31588922
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of inhibitor complexes of M-PMV protease with visible flap loops.
Wosicki S; Kazmierczyk M; Gilski M; Zabranska H; Pichova I; Jaskolski M
Protein Sci; 2021 Jun; 30(6):1258-1263. PubMed ID: 33786913
[TBL] [Abstract][Full Text] [Related]
3. High-resolution structure of a retroviral protease folded as a monomer.
Gilski M; Kazmierczyk M; Krzywda S; Zábranská H; Cooper S; Popović Z; Khatib F; DiMaio F; Thompson J; Baker D; Pichová I; Jaskolski M
Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):907-14. PubMed ID: 22101816
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional structure of a monomeric form of a retroviral protease.
Veverka V; Bauerová H; Zábranský A; Lang J; Ruml T; Pichová I; Hrabal R
J Mol Biol; 2003 Oct; 333(4):771-80. PubMed ID: 14568536
[TBL] [Abstract][Full Text] [Related]
5. The role of the S-S bridge in retroviral protease function and virion maturation.
Zábranská H; Tůma R; Kluh I; Svatos A; Ruml T; Hrabal R; Pichová I
J Mol Biol; 2007 Feb; 365(5):1493-504. PubMed ID: 17140600
[TBL] [Abstract][Full Text] [Related]
6. Luminometric method for screening retroviral protease inhibitors.
Horáková D; Rumlová M; Pichová I; Ruml T
Anal Biochem; 2005 Oct; 345(1):96-101. PubMed ID: 16125122
[TBL] [Abstract][Full Text] [Related]
7. The RNA binding G-patch domain in retroviral protease is important for infectivity and D-type morphogenesis of Mason-Pfizer monkey virus.
Bauerová-Zábranská H; Stokrová J; Strísovsky K; Hunter E; Ruml T; Pichová I
J Biol Chem; 2005 Dec; 280(51):42106-12. PubMed ID: 16257973
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of vimentin by different retroviral proteases.
Snásel J; Shoeman R; Horejsí M; Hrusková-Heidingsfeldová O; Sedlácek J; Ruml T; Pichová I
Arch Biochem Biophys; 2000 May; 377(2):241-5. PubMed ID: 10845700
[TBL] [Abstract][Full Text] [Related]
9. Structure of RC1339/APRc from Rickettsia conorii, a retropepsin-like aspartic protease.
Li M; Gustchina A; Cruz R; Simões M; Curto P; Martinez J; Faro C; Simões I; Wlodawer A
Acta Crystallogr D Biol Crystallogr; 2015 Oct; 71(Pt 10):2109-18. PubMed ID: 26457434
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the Basic Region of the Mason-Pfizer Monkey Virus Nucleocapsid Protein Affect Reverse Transcription, Genomic RNA Packaging, and the Virus Assembly Site.
Dostálková A; Kaufman F; Křížová I; Kultová A; Strohalmová K; Hadravová R; Ruml T; Rumlová M
J Virol; 2018 May; 92(10):. PubMed ID: 29491167
[TBL] [Abstract][Full Text] [Related]
11. Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage.
Sommerfelt MA; Petteway SR; Dreyer GB; Hunter E
J Virol; 1992 Jul; 66(7):4220-7. PubMed ID: 1602542
[TBL] [Abstract][Full Text] [Related]
12. Three active forms of aspartic proteinase from Mason-Pfizer monkey virus.
Zábranský A; Andreánsky M; Hrusková-Heidingsfeldová O; Havlícek V; Hunter E; Ruml T; Pichová I
Virology; 1998 Jun; 245(2):250-6. PubMed ID: 9636364
[TBL] [Abstract][Full Text] [Related]
13. Specific in vitro cleavage of Mason-Pfizer monkey virus capsid protein: evidence for a potential role of retroviral protease in early stages of infection.
Rumlová M; Ruml T; Pohl J; Pichová I
Virology; 2003 Jun; 310(2):310-8. PubMed ID: 12781718
[TBL] [Abstract][Full Text] [Related]
14. Integrase of Mason-Pfizer monkey virus.
Snásel J; Krejcík Z; Jencová V; Rosenberg I; Ruml T; Alexandratos J; Gustchina A; Pichová I
FEBS J; 2005 Jan; 272(1):203-16. PubMed ID: 15634344
[TBL] [Abstract][Full Text] [Related]
15. Nucleic Acid Binding by Mason-Pfizer Monkey Virus CA Promotes Virus Assembly and Genome Packaging.
Füzik T; Píchalová R; Schur FKM; Strohalmová K; Křížová I; Hadravová R; Rumlová M; Briggs JAG; Ulbrich P; Ruml T
J Virol; 2016 May; 90(9):4593-4603. PubMed ID: 26912613
[TBL] [Abstract][Full Text] [Related]
16. Expression of simian type D retroviral (Mason-Pfizer monkey virus) capsids in insect cells using recombinant baculovirus.
Sommerfelt MA; Roberts CR; Hunter E
Virology; 1993 Jan; 192(1):298-306. PubMed ID: 8517023
[TBL] [Abstract][Full Text] [Related]
17. The G-patch domain of Mason-Pfizer monkey virus is a part of reverse transcriptase.
Křízová I; Hadravová R; Štokrová J; Günterová J; Doležal M; Ruml T; Rumlová M; Pichová I
J Virol; 2012 Feb; 86(4):1988-98. PubMed ID: 22171253
[TBL] [Abstract][Full Text] [Related]
18. Membrane Interactions of the Mason-Pfizer Monkey Virus Matrix Protein and Its Budding Deficient Mutants.
Kroupa T; Langerová H; Doležal M; Prchal J; Spiwok V; Hunter E; Rumlová M; Hrabal R; Ruml T
J Mol Biol; 2016 Nov; 428(23):4708-4722. PubMed ID: 27725181
[TBL] [Abstract][Full Text] [Related]
19. Backbone resonance assignment of protease from Mason-Pfizer monkey virus.
Veverka V; Bauerová H; Zábranský A; Pichová I; Hrabal R
J Biomol NMR; 2001 Jul; 20(3):291-2. PubMed ID: 11519753
[No Abstract] [Full Text] [Related]
20. Comparison of inhibitor binding in HIV-1 protease and in non-viral aspartic proteases: the role of the flap.
Gustchina A; Weber IT
FEBS Lett; 1990 Aug; 269(1):269-72. PubMed ID: 2201571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
